INTERVIEW · HEALTH · Caring Cross · Milken Global Conference 2025 · 8:28 · Released September 30, 2026
"Only 25% of eligible patients get CAR-T therapy. In low-income countries it's under 1%." - Milken Global 2025
Nonprofit Caring Cross on making curative cell and gene therapies affordable: teaching hospitals in Brazil, the UAE and Nigeria to manufacture CAR-T cells locally at a tenth of the US cost, and why a $3 million cure helps nobody who can’t reach it.
HealthcareScience
Up next
More like this11:19
Technology, Cloud and the Future, GCC Conclave 2019
Ian Khan · GCC Conclave 2019
3:43
Reducing the Friction Between Government and People | Ian Khan at WGS 2024
Government Experience
9:26
Applying 'Never Events' Thinking to Clinical AI | Dr Erin Palm, Infinitus
ViVE 2026
9:04
It Is Impossible to Debank Someone | Dom Kwok, EasyA
Consensus 2025 Toronto
8:32
Ophir Kagan, Co-Founder & CEO of Maitri Health at HLTH2025 with Ian Khan
HLTH 2025
12:38
We Are Automating on Top of Trust We Never Had | Tricia Wang
Consensus 2025 Toronto
7:18
Jenna DiRito, Co-Founder & COO of Revalia Bio at HLTH2025 with Ian Khan
HLTH 2025
9:38
Data Is Oil, and We Like to Be Fracking | Kempton Presley, AdhereHealth
ViVE 2026
11:13
"53% of leaders want more productivity while 80% of workers say they're maxed out." - Milken Global 2025
Microsoft · Milken Global Conference 2025
9:28
American Medicine Is the Best in the World. The System Is Not | Malinka Walaliyadde, AKASA
ViVE 2026